Hibernicor News 

Geographic Inequalities of Donor Organ Allocation September 8, 2018- In response to a blistering critical comment to a donor lung allocation inequity lawsuit; HRSA Administrator George Sigounas determined that the Organ Procurement and Transplantation network has “not justified and cannot justify the use of donation service areas.” Now the OPTN/UNOS Ad Hoc Geography Committee is urgently seeking additional public comments on three proposed frameworks for organ distribution. […]
Top 10 Heart Transplant Centers of 2017* July 17, 2018- 1. Cedars-Sinai Medical Center 2. Vanderbilt University Medical Center 3. New York-Presbyterian/Columbia 4. University of Washington Medical Center 5. Duke University Hospital 6. Stanford University Medical Center 7. The Hospital of the University of Pennsylvania 8. Baylor University Medical Center 9. Florida Hospital Medical Center 10. Tampa General Hospital *based on 2017 UNOS data.
The Asporto // Heart Preservation Device tries on a new carbon fiber shell. February 27, 2018- As a medical student at the University of Minnesota, I was fortunate to have been in an innovative environment were new discoveries were a daily occurrence. This was inside the former cardiovascular and thoracic surgical laboratories where C. Walton Lillehei pioneered open heart surgery and used the first external pacemaker designed by Earl Bakken. In 1998, I was awarded the Howard […]
Hibernicor Develops New Asporto Circuit Board January 26, 2018- Hibernicor has developed a new micro-controller interface circuit board to smaller package.  Specifically this printed circuit board adds important features of temperature monitoring with a thermistor, robust componentry, and lightweight surface mounted resistors.  The circuit board uses custom designed schematics and design validated for quality manufacturing to further improve the safety and reliability of the […]
Why Will Perfusion Systems for Donor Heart Preservation Become The Standard-of-Care? January 3, 2018- Currently almost all organs are preserved using an insulated cooler and ice. This simple effective method has been the standard-of-care since the first heart transplant 50 years ago. Why?  Because it works; the heart has a high metabolism which when cooled down – decreases its energy utilization by 80%.  The reduction of metabolism has been the […]
Dr. Rivard introduces the Asporto // Heart Preservation Device December 12, 2017- Hibernicor’s signature product, Asporto, improves and prolongs preservation of donor hearts. The purpose of Asporto is to increase the number of usable hearts available for donation by improving the donor organ quality by 20%. The device consists of a microcontroller with touch-screen display, insulated container, peristaltic pump, power converter and a sterile disposable kit.  Contact us for even more […]
Top 10 Heart Transplant Centers of 2016* August 5, 2017- 1. Cedars-Sinai Medical Center 2. Vanderbilt University Medical Center 3. Duke University Hospital 4. New York-Presbyterian/Columbia 5. UCLA Medical Center 6. The Hospital of the University of Pennsylvania 7. Baylor University Medical Center 8. University of Washington Medical Center 9. Stanford University Medical Center 10. Tufts Medical Center *based on 2016 UNOS data.
Organ Recovery Systems Receives FDA Warning Letter April 20, 2017- Chicago District Office 550 W. Jackson Blvd., 15th Floor Chicago, IL 60661 Telephone: (312) 353-5863 Fax: (312) 596-4187   April 20, 2017   WARNING LETTER   CHI-7-17       UPS NEXT DAY SIGNATURE REQUIRED                                                                                                                                                                                                         Mr. David C. Kravitz, President & CEO Organ Recovery Systems, Inc. One Pierce Place, Suite 475 West Itasca, IL 60142 […]
FDA Warns Of Potentially Contaminated SPS-1 Static Preservation Solution Distributed by Organ Recovery Systems March 9, 2017- Date Issued: March 9, 2017 Audiences: Organ and tissue procurement organizations Organ and tissue transplantation centers Health Care Providers who conduct organ and tissue transplant procedures Health Care Providers who care for organ and tissue transplant recipients Operating Room Managers, Directors and Staff Risk Managers Patients considering organ or tissue transplantation Organ and tissue recipients Medical […]
UK Publishes Recommendations for Transmedics Organ Care System August 5, 2016- The UK National Institute for Health and Care Excellence (NICE) completed a comprehensive review of the literature regarding normothermic extracorporeal preservation of hearts for transplantation following donation after brainstem death. This review comes following published and unpublished research trials using the Transmedics Organ Care System. Heart transplantation usually involves hypothermic storage of donor heart until […]
The Top 10 Heart Transplant Centers of 2015: May 28, 2016- 1. Cedars-Sinai Medical Center 2. Stanford University Medical Center 3. Vanderbilt University Medical Center 4. The Hospital of the University of Pennsylvania 5. UCLA Medical Center 6. New York-Presbyterian/Columbia 7. Baylor University Medical Center 8. Duke University Hospital 9. Newark Beth Israel Medical Center 10. Cleveland Clinic *based on 2015 UNOS data.
Design Evolution of the Asporto // Heart Preservation Device March 12, 2016- Hibernicor’s Asporto // Heart Preservation Device has undergone a design upgrade improving the usability and functionality of the heart container. This improvement follows proof-of-concept testing done at the University of Minnesota Experimental Surgical Services laboratories. The Asporto device provides perfusion of cardioplegia to the donor heart using a computer-controlled peristaltic pump in a thermoelectrically cooled […]
Hibernicor Founder Responds to FDA Invitation for Proposed Industry Guidance March 6, 2016- Docket Number: FDA-2012-N-1021 Docket Name: Food and Drug User Fee and Modernization Act; Notice to Public of Web Site Location of Fiscal Years Proposed Guidance Document Dr. Andrew Rivard’s response to FDA invitation to comments on utilizing animal studies to evaluate the safety of organ preservation devices and solutions: What are the potential limitations of an […]
Hibernicor Sponsors Research of UNOS Big Data to Predict Geographic Disparities in Organ Donation January 22, 2016- Hibernicor LLC has initiated a project with the George Mason University to analyze over a million records of nationwide heart transplant data provided by the United Network of Organ Sharing (UNOS) to determine if there are any regional differences in cold ischemia time and organ wastage.  The research is designed to identify geographical disparities that may […]
Finalist – Emerging Medical Innovation Valuation Competition April 14, 2015- Hibernicor’s Asporto heart transplant device has been selected as a finalist in the Emerging Medical Innovation Valuation Competition, as part of the Design of Medical Devices Conference at the University of Minnesota. Hibernicor was one of five finalists among 24 submissions from 10 states and four countries. Design of Medical Devices Conference April 13-16 2015 […]
Semi-finalist – 2009 Minnesota Cup business plan competition June 16, 2009- With over 1000 entries to the 2009 Minnesota Cup, Hibernicor ranked in the Top 10  in the Biosciences category following a first round of judging.  The Minnesota Cup is an annual, statewide competition, which seeks out aspiring entrepreneurs and their breakthrough ideas.  The competition was hosted by the University of Minnesota and Wells Fargo for its fifth year.  
Hibernicor begins discussions with the FDA on the pre-clinical research protocol October 31, 2008- Hibernicor met with representatives of FDA’s Center for Devices and Radiologic Health (CDRH) on October 30th, 2008.  Based upon the discussions with the FDA, Hibernicor has finalized the pre-clnical research protocol necessary for 510k approval.
Research study shows that Asporto limits degradation of the donor heart May 1, 2008- A recent study from the University of Minnesota using the Asporto heart preservation device was published in a nationally recognized peer reviewed journal. The study demonstrated that intermittent antegrade cardioplegia maintains a significantly higher pH in donor hearts. The study involved a series of animal hearts preserved using the conventional method of donor heart transportation […]
Praesto software installed at the University of Minnesota August 31, 2007- The electronic research record Praesto was implemented this month at the University of Minnesota’s Experimental Surgical Services. Richard W. Bianco, the GLP laboratory’s director was extremely satisfied with the conversion to the electronic format that will be used initially in the preclinical testing of new heart valves.
Asporto featured at the 27th Annual Meeting of the International Society for Heart and Lung Transplantation April 26, 2007- Research completed at the University of Minnesota was presented at the 27th Annual Meeting of the International Society for Heart Lung Transplant. The study demonstrated the effectiveness of intermittent antegrade cardioplegia in reducing damage during prolonged storage of isolated heart.
Winner – University of St. Thomas business plan competition December 12, 2006- On December 12th, 2006, the University of Thomas Schulze School of Entrepreneurship held its semiannual business plan competition.  Jordan Milan of Hibernicor, LLC was awarded first place for her presentation outlining the startup company to a panel of judges.
Hibernicor featured in Twin Cities Business Magazine November 1, 2006- Andrew Rivard, a research consultant at the University of Minnesota’s Department of Surgery and a resident physician at the Unversity of Florida, believes he has a better way to deliver donor hearts.  Traditionally this has been performed via a basic handheld cooler. However, Rivard says this method has a key limitation…
Semi-finalist – 2006 Minnesota Cup business plan competition September 7, 2006- With over 650 entries to the 2006 Minnesota Cup, Hibernicor ranked in the Top 10 following a second round of judging. The Minnesota Cup is an annual, statewide competition, which seeks out aspiring entrepreneurs and their breakthrough ideas. The competition was hosted by the University of Minnesota and Wells Fargo for its second year.
Hibernicor featured in the New Technology Showcase at the Medical Alley (now LifeScience Alley) 2005 Conference October 5, 2005- Together, Hibernicor and Minnetronix successfully launched the prototype heart preservation device as one of eight companies selected to participate in the New Technology Showcase at the Medical Alley Annual Conference & Expo, October 5 & 6, 2005 (now known as Medical Alley Association ).
First preclinical heart transplant August 25, 2005- In a Minnesota Medical Foundation funded study, Dr. Ranjit John transplanted the first porcine hearts stored in a prototype heart preservation device at the University of Minnesota, Experimental Surgical Services. The study successfully demonstrated the feasiblity of system as it was designed for extended heart preservation.